D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
SGTX holding history
Sigilon Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SGTX overviewAll 13F holders of SGTXFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −41,455−100.0% | Sold out | Holders |
| Q1 2022 | 41,455 | $61.0K | <0.1% | −4,787−10.4% | Reduced | Holders |
| Q4 2021 | 46,242 | $128.0K | <0.1% | +46,242 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −14,444−100.0% | Sold out | Holders |
| Q2 2021 | 14,444 | $155.0K | <0.1% | +14,444 | New | Holders |